Table 2. Associations of constructed PRS with skin cancer traits in MGI.
PRS (Number of SNPs) |
Skin cancer n = 4,503 (1,501 / 3,002)d |
Melanoma n = 1,896 (617 / 1,279)d |
Basal cell carcinoma n = 1,303 (419 / 884)d |
Squamous cell carcinoma n = 836 (273 / 563)d |
|
---|---|---|---|---|---|
PRS based on GWAS catalog | |||||
Melanoma (29) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.3 (1.26,1.34) 2.7x10-53 0.57 (0.56,0.58) 6.8, 0.56 0.14 |
1.48 (1.41,1.56) 1.3x10-56 0.61 (0.59,0.62) 7.6, 0.47 0.093 |
1.3 (1.23,1.38) 7.3x10-19 0.58 (0.56,0.6) 12, 0.13 0.093 |
1.23 (1.14,1.32) 4.3x10-8 0.55 (0.53,0.58) 2.2, 0.97 0.091 |
Basal cell carcinoma (32) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.32 (1.27,1.36) 8x10-60 0.58 (0.56,0.59) 9.7, 0.29 0.14 |
1.31 (1.25,1.37) 7.2x10-28 0.58 (0.56,0.59) 13, 0.1 0.093 |
1.65 (1.56,1.75) 3.6x10-65 0.64 (0.62,0.66) 15, 0.066 0.091 |
1.32 (1.23,1.42) 1.4x10-14 0.58 (0.55,0.6) 12, 0.17 0.091 |
Squamous cell carcinoma (18) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.25 (1.21,1.3) 4.8x10-42 0.56 (0.55,0.57) 8.1, 0.42 0.14 |
1.32 (1.26,1.39) 5.1x10-31 0.58 (0.56,0.59) 6.2, 0.63 0.093 |
1.35 (1.28,1.43) 7.9x10-26 0.58 (0.56,0.6) 5.9, 0.66 0.093 |
1.26 (1.17,1.35) 1.8x10-10 0.55 (0.53,0.58) 18, 0.025 0.091 |
PRS based on latest GWAS | |||||
Melanoma (20) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.31 (1.27,1.36) 3.5x10-55 0.57 (0.56,0.58) 4.9, 0.76 0.14 |
1.49 (1.42,1.57) 1.2x10-55 0.6 (0.59,0.62) 13, 0.13 0.093 |
1.39 (1.3,1.47) 7.9x10-27 0.59 (0.58,0.61) 16, 0.04 0.092 |
1.25 (1.16,1.34) 4x10-9 0.55 (0.53,0.58) 7.6, 0.47 0.091 |
Basal cell carcinoma (28) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.32 (1.28,1.37) 5.8x10-61 0.58 (0.57,0.59) 5.9, 0.66 0.14 |
1.33 (1.27,1.4) 5.7x10-32 0.58 (0.57,0.6) 20, 0.012 0.093 |
1.62 (1.53,1.71) 2.8x10-60 0.63 (0.61,0.65) 6.5, 0.59 0.091 |
1.34 (1.25,1.44) 1.2x10-15 0.58 (0.55,0.6) 15, 0.052 0.091 |
Squamous cell carcinoma (10) |
PRS ORa P-valuea AUCb HL χ2, P-value c Brier Score |
1.34 (1.3,1.38) 1.1x10-70 0.58 (0.57,0.6) 13, 0.12 0.14 |
1.42 (1.36,1.49) 6.1x10-51 0.59 (0.58,0.61) 14, 0.082 0.093 |
1.47 (1.4,1.56) 1.8x10-43 0.61 (0.59,0.63) 7.1, 0.53 0.092 |
1.4 (1.31,1.5) 2.1x10-21 0.59 (0.56,0.61) 6.4, 0.61 0.091 |
a Association of each cancer with continuous PRS that were transformed to standard normal distribution. Point estimates, 95% confidence intervals and P- values are obtained by fitting Firth’s bias-corrected logistic regression adjusted for age, sex, batch and PC1-4 to the full data.
b Area under the curve of the receiver operating characteristic (ROC) curve with 95% confidence intervals calculated using the test data after fitting a model with the training data.
c Hosmer-Lemeshow Goodness-of-Fit test for the test data after fitting a model with the training data
d Number of cases in training / test set